Getinge continues to enhance its operational efficiency and provides updated earnings forecast for the 2010 financial year

Getinge continues to enhance its operational efficiency and provides
updated earnings forecast for the 2010 financial year

Getinge 11 January, 2011

For the fourth quarter of 2010, the Getinge Group will make further
provisions for planned restructuring in addition to those already
announced. Restructuring expenses for the fourth quarter of 2010 will
total SEK 117 million. Of this amount, SEK 9 million pertains to the
integration of Datascope. The remaining provisions for additional
restructuring activities in the fourth quarter, amounting to SEK 108
million, pertain to the Medical Systems business area. In total,
restructuring expenses for the 2010 financial year will amount to SEK
180 million.

Medical Systems intends to comprehensively restructure the production of
perfusion products (ventilators, tubing sets etc.) in Germany. As a
result of the restructuring project, the production unit in Hirrlingen
will be closed, as will the logistics centre in the German city of
Hechingen. The business area's production in Antalya, Turkey, will be
expanded to take over further production from Germany. After the
restructuring project has been implemented in its entirety at the
beginning of 2012, operations will be concentrated to two production
units: Hechingen for machine-based production and Antalya for more
manual production. In future, logistics and inventory will be handled by
an external partner. The business area has started negotiations with the
personnel at the units affected by the restructuring project. The
restructuring of the perfusion operations is expected to lead to annual
savings of approximately SEK 60 million as of 2012.

Also taking into consideration further restructuring expenses of
approximately SEK 108 million that will be charged to the 2010 financial
year, the Group expects pre-tax earnings to amount to slightly more than
SEK 3,100 million, which is in line with the earnings forecast provided
in conjunction with the report for the third quarter.

For further information:
Johan Malmquist, President and CEO
Ulf Grunander, CFO
Telephone: +46 (0)10-335 00 00

GETINGE GROUP is a leading global provider of products and systems that
contribute to quality enhancement and cost efficiency within healthcare
and life sciences. We operate under the three brands of ArjoHuntleigh,
GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound
management solutions. GETINGE provides solutions for infection control
within healthcare and contamination prevention within life sciences.
MAQUET specializes in solutions, therapies and products for surgical
interventions and intensive care.